Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clenbuterol Detectability and Physiological Response
NCT03860870Completed
- Sponsor
- University of Copenhagen
- Start
- Mar 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Clenbuterol with Placebo (2 arms). Primary endpoint: Blood clenbuterol concentration at 240 hours. Started Mar 2019; status: completed.
02
Drugs
clenbuterol
Beyond the preview
Go deeper on NCT03860870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03860870.